We are happy to share that Eduard Avetisyan has joined the Board of Advisors of ABI! Eduard Avetisyan is an alumni of Yerevan State University and YerPhI with PhD in high energy particle physics and currently, he leads the IT team in the Hamburg unit of the EMBL.
ABI received a research grant from the Swedish Institute as part of a collaboration with the Swedish University of Agricultural Sciences at Lund (SLU), Sweden, and Telavi State University, Georgia, to widen the network and training activities around the topic production of grapes in a changing climate with a focus on genomics.
ABI has launched a fundraising campaign for setting up a computing infrastructure on the reArmenia platform. With the raised money, ABI will build the first publicly accessible centralized and well-maintained computing infrastructure in Armenia to safely store, annotate and analyze Armenian genomics data. This computing infrastructure will be open for all the students and scientists engaged in life science training and research in Armenia.
ABI in collaboration with the Higher School of Economics in Moscow is holding a mini-workshop spanning a wide range of topics in Bioinfromatics and Computational Genomics. The event is interesting for researchers and students who are interested in bioinformatics. Some new projects that will be offered by ABI will also be presented to prospective students.
We are glad to announce a strategic collaboration with Agenus, a US-based biotech company specializing in innovative forms of cancer treatment, including the discovery and development of immuno-oncology therapies. Together with the scientists at Agenus, ABI will form a team of students and researchers to study cancer metastases and identify potential biomarkers and targets for cancer immunotherapies.This collaboration is also part of our long-term vision of supporting biotech developments in… Read More »ABI starts a strategic collaboration with Agenus
In February 2021, ABI was established as a non-profit scientific-educational foundation aimed at promoting scientific progress in bioinformatics and developing the human capital for boosting developments in the biotech industry and precision medicine. Now, after one year of operation, it’s time to share our first Annual Report! Learn more about our vision, activities, and glance over some key numbers of 2021 by reading the report.
We are excited to announce that ABI has received a research grant from the Enterprise Incubator Foundation (EIF)! With the provided support, ABI’s founding director Lilit Nersisyan and three ABI students will study the effect of cigarettes and e-cigarettes on the microbiome. This is an important milestone for ABI, and we are looking forward to progressing our research with the help of EIF and through the support of PMI SCIENCE!
During TEDxYerevan 2021 ABI’s founding director Lilit Nersisyan had a talk explaining her and her colleagues’ search for a solution for building expertise in genome bioinformatics in Armenia. She explained the role of ABI as a source of human capital that will eventually drive developments in the genomics heavy biotech sector.
As ABI is growing, we are excited to introduce our newly-formed advisory board. The board consists of leading experts in bioinformatics & life sciences, biotech, finances and marketing that have an active contribution to ABI’s endeavors and provide their time and support to our cause. Let’s give them a warm welcome!